Nelson Leung, MD, Mayo Clinic, Rochester, MN, discusses measurable residual disease (MRD) negativity in AL amyloidosis patients undergoing kidney transplantation. Dr Leung discusses a paper he co-authored investigating the impact of MRD negativity with Mass-Fix as a surrogate on the outcomes of AL amyloidosis patients.
Giampaolo Merlini, MD, Foundation IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy, talks on AL amyloidosis management during the pandemic, specifically highlighting the fragility of this patient population and how telemedicine can avoid unnecessary contact.
AA amyloidosis is characterized by extracellular tissue deposition of fibrils comprised of fragments of intact serum amyloid A protein. Luis Quintana, MD, PhD, Hospital Clínic de Barcelona, Spain, discusses serum amyloid A protein (AA) and other forms of amyloidosis, along with AA amyloidosis management.
Jonas Wixner, MD, PhD, Umeå University, Umeå, Sweden, discusses his ISA 2020 talk on 99mTc-DPD scintigraphy and how it predicts amyloid fibril type in hereditary transthyretin (ATTR) amyloidosis.
Animated explanation of LECT2 Amyloidosis, brought to you by the AL2A.
Morie Gertz, MD, Hematologist, Chair Emeritus Internal Medicine, Mayo Clinic, gives an overview of immunoglobulin light chain-associated (AL) amyloidosis and how the disease is currently managed. As Dr. Gertz explains, AL amyloidosis is a rare blood disorder associated with the overproduction of amyloid, which leads to the deterioration of vital organs, most notably the heart, …
“Hello, Amy” a song written about dealing with the disease amyloidosis, was originally released on my 2012 release entitled ‘What To Keep & Let Go’. After many months of working with talented musicians and singer/songwriters, “Hello, Amy” is coming into the light as a compilation project to raise awareness and funds for research of this …
Meet Rick, living with hereditary transthyretin-mediated (hATTR) amyloidosis. When Rick’s symptoms began to pile up, he thought it might have been due to old age. However, Rick reached his tipping point when his symptoms got worse. His brother recommended that Rick get tested for hATTR amyloidosis, which led to the right diagnosis.
In this video, Katie Agre, MS, CGC, Genetic Counselor at Mayo Clinic, Rochester, Minnesota, discusses hereditary amyloidosis and the importance of genetic counseling and testing. Transthyretin (TTR) amyloidosis is a hereditary condition caused by mutations in the TTR gene, therefore, genetic counseling is considered to be an important part of patient care.